Skip to search formSkip to main contentSkip to account menu

Q 35

Known as: Q-35 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
We present discovery observations of a quasar in the Canada-France High-z Quasar Survey (CFHQS) at redshift z = 6.44. We also use… 
1996
1996
Comparative pharmacokinetics and tolerability were studied in healthy elderly volunteers for two new fluoroquinolones… 
1995
1995
The bactericidal effects of Q-35, sparfloxacin, tosufloxacin, and ofloxacin on 18 strains of methicillin-resistant Staphylococcus… 
1995
1995
To investigate emerging fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan, we compared the in vitro… 
1995
1995
Q-35, a new fluoroquinolone, was evaluated for its in vitro and in vivo antibacterial activities. In vitro antibacterial activity… 
1994
1994
Q-35, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3- methylaminopiperidine-1-yl)-4-oxyquinoline-3-carboxylic acid, has… 
Highly Cited
1993
Highly Cited
1993
A newly developed fluoroquinoline, Q-35 (8-OCH3), in which a methoxy group was substituted at the 8 position of the quinoline… 
1993
1993
New carboxyquinolone drugs, including the recently developed Q-35, were evaluated for their in vitro potency against five… 
1993
1993
The in vitro potency and in vivo efficacy of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae were investigated by… 
1992
1992
The in vitro activity of Q-35, an 8-methoxy fluoroquinolone, was compared with those of ofloxacin, ciprofloxacin, tosufloxacin…